A Study of Live Biotherapeutic Product MRx0518 With Hypofractionated Radiation Therapy in Resectable Pancreatic Cancer

Clinical trial NCT04193904 · TERMINATED

Trial details

NCT number: NCT04193904
Sponsor: 4D pharma plc
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2019-12-20
Primary completion: 2023-05-08
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.